Cyberkinetics Inc.'s Andara(TM) Combination Product Yields Nerve Regeneration And Functional Recovery In Model for Chronic Spinal Cord Injury

FOXBOROUGH, Mass.--(BUSINESS WIRE)--April 25, 2006--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; "Cyberkinetics") today announced that the Company's research collaborators at Indiana University and the Center for Paralysis Research at Purdue University presented study results that demonstrate - for the first time - that Cyberkinetics' Andara(TM) Oscillating Field Stimulator (OFS) PLUS System, a combination product, induced nerve regeneration and functional recovery in a preclinical model of chronic, or long-term, spinal cord injury. These new findings build on the previously demonstrated ability of Cyberkinetics' Andara(TM) OFS Device, used alone, to restore sensation and some function in a Phase Ia clinical trial of ten participants who received the device within 18 days of their injuries.